IIL to invest Rs 75 cr to set up viral antigen manufacturing plant in Telangana

By: |
November 25, 2020 6:29 PM

Biologicals firm Indian Immunologicals Ltd (IIL) on Wednesday said it will invest Rs 75 crore to commission a new viral antigen manufacturing facility in Telangana to increase its capacity for supplying vaccines.

Covid-19 vaccine, SanofiIIL exports various human and animal vaccines to over 50 countries and currently employs around 1,300 people.

Biologicals firm Indian Immunologicals Ltd (IIL) on Wednesday said it will invest Rs 75 crore to commission a new viral antigen manufacturing facility in Telangana to increase its capacity for supplying vaccines. The new facility will be specially designed as a multi-product facility and cater to the need for viral vaccines in the pipeline, including for dengue, zika and varicella, IIL said in a statement.

The company also plans to utilise the facility to manufacture COVID-19 vaccines post completion of its R&D with Griffith University, Australia, it added. The company also inaugurated a new sterile filling facility that was commissioned last year to increase its capacity to supply lifesaving vaccines such as the Anti Rabies Vaccine (ARV) — Abhayrab, IIL said.

“We are optimistic about the strategic investment as India is one of the key growth markets. As we mark as one of the major players on the pediatric and rabies vaccine, this expansion of our manufacturing facility is our commitment to securing a healthy and sustainable future,” IIL MDK Anand Kumar said.

“This facility has been specially designed to cater to the need for various viral vaccines and it will boost our manufacturing capacity by 35 per cent. The new plant is expected to be ready for operation by October 2021,” IIL Deputy MD Prasanna Deshpande said.  IIL exports various human and animal vaccines to over 50 countries and currently employs around 1,300 people.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Many people not turning up for second COVID jab in Odisha: Official
2Covid-19: Mumbai comes long way, latest sero finds 86% resident have antibodies, check details
3No need for Covid booster doses in India at this stage, say experts